About
Michael Cohen is co-practice group leader of Brown Rudnick’s Global Life Sciences Group and the firm’s Emerging Growth Companies & Venture Capital Group. He advises on high-profile matters in the life sciences and technology sectors, representing early stage and mid-market companies in corporate structuring, M&A, joint ventures, and financing transactions.
Practice areas
Mergers and AcquisitionsVenture CapitalLife SciencesCorporate LawPrivate Equity
Office
Expertise
Life SciencesTechnologyVenture CapitalPrivate Equity
